ArticleThe Journal of allergy and clinical immunology2018

Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation.

Valentina Capo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.